A circadian based inflammatory response – implications for respiratory disease and treatment by Comas, M et al.
Sleep Science and PracticeComas et al. Sleep Science and Practice  (2017) 1:18 
DOI 10.1186/s41606-017-0019-2REVIEW Open AccessA circadian based inflammatory
response – implications for
respiratory disease and treatment
Maria Comas1,2,5* , Christopher J. Gordon1,7, Brian G. Oliver2,3,8, Nicholas W. Stow9, Gregory King2,4,6,10,
Pawan Sharma2,3,8, Alaina J. Ammit2,8, Ronald R. Grunstein1,5 and Craig L. Phillips1,2,6,10Abstract
Circadian clocks regulate the daily timing of many of our physiological, metabolic and biochemical functions. The
immune system also displays circadian oscillations in immune cell count, synthesis and cytokine release, clock gene
expression in cells and organs of the immune system as well as clock-controlled genes that regulate immune function.
Circadian disruption leads to dysregulation of immune responses and inflammation which can further disrupt circadian
rhythms. The response of organisms to immune challenges, such as allergic reactions also vary depending on time of the
day, which can lead to detrimental responses particularly during the rest and early active periods. This review evaluates
what is currently known in terms of circadian biology of immune response and the cross-talk between circadian and
immune system. We discuss the circadian pattern of three respiratory-related inflammatory diseases, chronic obstructive
pulmonary disease, allergic rhinitis and asthma. Increasing our knowledge on circadian patterns of immune responses
and developing chronotherapeutic studies in inflammatory diseases with strong circadian patterns will lead to preventive
measures as well as improved therapies focussing on the circadian rhythms of symptoms and the daily variation of the
patients’ responses to medication.
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Jürgen Aschoff traced back the interest in biological
rhythms to the Greek poet Archilochus of Paros (ca. 680–
640 BC) who wrote “recognize which rhythms govern
man” (Aschoff 1974). More than 2500 years later
biological rhythms are known to ‘govern’ many aspects in
human behaviour, physiology, metabolism, disease symp-
toms and response to treatment in a rhythmic fashion
with the circadian clock as time-keeper.
The circadian clock ensures that the processes it
regulates recur every day at the most optimal times of
the day for the functioning and survival of the organism
in a coordinated manner (Dibner et al. 2010). Disturb-
ance of circadian rhythms due to, for example, shift-work* Correspondence: Maria.comassoberats@sydney.edu.au
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(http://creativecommons.org/publicdomain/ze(Kecklund and Axelsson 2016), circadian disorders or dys-
regulation of rhythmicity (McHill and Wright 2017; Mor-
ris et al. 2016; Kadono et al. 2016; Gamaldo et al. 2014;
Dickerman et al. 2016) increase the morbidity risk of car-
diovascular disease (Reutrakul and Knutson 2015), meta-
bolic disease (Arble et al. 2010) and cancers (Levi and
Schibler 2007). Recent work has shown that disruption of
the circadian clock leads to dysregulation of immune re-
sponses which underlie the pathophysiological basis of
disease, suggesting an important regulatory role of the cir-
cadian system. This relates to daily oscillations in the
number of circulating innate and adaptive immune cells,
cytokine and chemokine levels and expression of adhesion
molecules that are integral components of the immune re-
sponse (reviewed in (Labrecque and Cermakian 2015;
Nakao 2014; Scheiermann et al. 2013; Cermakian et al.
2013; Cermakian et al. 2014)). Overall, multiple studies
suggest that pro-inflammatory activity is elevated during
rest and induces sleep whereas anti-inflammatory media-
tors are induced upon awakening and inhibit sleep (Bryantle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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et al. 2001; Kubota et al. 2001; Kubota et al. 2001; Kushi-
kata et al. 1999; Krueger 1987; Kubota et al. 2000). Inter-
estingly, both symptom intensity and response to
treatment of many illnesses, including autoimmune or in-
flammatory diseases, vary across the 24-h day (Smolensky
et al. 2007; Smolensky et al. 2012; Buttgereit et al. 2015).
For this reason, chronotherapy which entails optimal
timing of administration of treatments for disease aims to
ensure that effectiveness is maximized whilst any toxic
side effects are minimised (Smolensky et al. 2016).
In the context of inflammation, it is crucial that we
increase our understanding of the circadian patterns of
immune responses and how they are regulated by the
central and peripheral clocks to enable discovery of
chronotherapeutic approaches for optimal timing of
therapies and even preventive measures for inflamma-
tory disease, allergies and infections. This descriptive
review focuses on the relationship between circadian
clocks and the immune system and inflammatory
diseases and discusses the potential for developing new
therapeutic approaches. We discuss the urgent need of
bridging all the fundamental knowledge established in
chronobiology with disease to develop novel transla-
tional strategies that take time of day into account.
How is entrainment achieved in circadian
rhythms?
Periodic environmental changes in, for example, light
intensity, temperature, food availability and predator
pressure amongst many others have led to the evolution
of biological clocks in most species (Daan 1981).
Circadian clocks continue to oscillate in the absence of
time cues but, in this scenario, their period is not equal
to 24 h. Instead, they display rhythmicity characterized
by their individual endogenous circadian period, τ, which
is circa 24 h but not necessarily exactly 24 h. In the
presence of an external synchronizer, called Zeitgeber
(from German Zeit “time” and Geber “giver” (Aschoff
1951; Aschoff 1958)) with a period T, τ is adjusted daily
to equal T (Pittendrigh 1981). In addition, a stable and
distinctive phase angle difference between the Zeitgeber
and the circadian clock results (Daan 2000; Hirschie
Johnson et al. 2003). This process of synchronization of
circadian clocks to the external Zeitgebers is called
entrainment. For the purposes of this review, entrain-
ment will refer to the central clock aligning to the
external time cues, while synchronization will refer to
the alignment of the central and peripheral clocks
relative to each other.
The light-dark cycle due to the rotation of the Earth
with a period T of 24 h is a very reliable signal organisms
use to entrain circadian rhythms. Light is the most im-
portant Zeitgeber for many organisms (Pittendrigh 1981;Daan 2000; Aschoff 1960; Beersma et al. 2009). The
specific properties characterizing the light signal that will
contribute to entraining the circadian clock of an organ-
ism, e.g. duration of light and dark signals (Comas et al.
2006; Comas et al. 2007), light intensity (Boulos 1995),
spectral composition (Boulos 1995; Revell et al. 2005; van
de Werken et al. 2013; Cajochen et al. 2005) or twilight
duration (Comas and Hut 2009; Aschoff and Wever 1965;
Boulos et al. 2002; Boulos and Macchi 2005; Roenneberg
and Foster 1997), will determine the robustness of
entrainment. Other time cues, particularly food avail-
ability, have been proven to be potent synchronizers
as well (Dibner et al. 2010). In mammals, the supra-
chiasmatic nucleus (SCN) located in the hypothal-
amus at the base of the brain is the ‘master circadian
clock’ that generates and regulates the body’s circa-
dian rhythms and synchronizes them to the environ-
mental 24-h light-dark cycle.
In addition to the master clock, peripheral clocks are
found in virtually all individual cells in the body where
they coordinate cellular processes – most notably within
organs and other tissues including spleen, lymph nodes
and different cells of the immune system (e.g. macro-
phages, monocytes, neutrophils or natural killers) (Keller
et al. 2009; Boivin et al. 2003; Bollinger et al. 2011). All
peripheral clocks are synchronized daily and coordinated
by the SCN via the hypothalamic pituitary adrenal (HPA)
axis and the autonomic nervous system (ANS) (Dibner
et al. 2010; Nader et al. 2010; Kalsbeek et al. 2012).
Peripheral clocks can also be synchronized and even
uncoupled from the SCN by, for example, food availability
or temperature (Brown et al. 2002; Mistlberger and
Marchant 1995; Damiola 2000; Stokkan et al. 2001; Comas
et al. 2014). However, in mammals the SCN is the only
component of the circadian system that receives light
input to maintain circadian synchronization with other
peripheral clocks (Bell-Pedersen et al. 2005) (Fig. 1).
A molecular circadian clock is ticking in each of
our cells
The mammalian molecular clock machinery is present
in virtually all cell types including immune cells (see
reviews for detailed descriptions of the molecular clock
machinery (Labrecque and Cermakian 2015; Papazyan
et al. 2016; Herzog et al. 2017; Partch et al. 2014;
Takahashi 2017; Stojkovic et al. 2014)). In brief, it is
composed of a set of proteins that generate two inter-
locking auto-regulatory transcription-translation feed-
back loops (TTFLs) (Fig. 2). For clarity reasons, we will
use italics when we refer to genes and capital letters
when we refer to proteins throughout the text. The main
loop is composed of a positive and a negative arm.
Circadian Locomotor Output Cycles Kaput (CLOCK), or
its paralog NPAS2(DeBruyne et al. 2006), and brain and
Fig. 1 Light input is received daily by specialized photoreceptor cells in the retina, the intrinsically photosensitive retinal ganglion cells (ipRGCs)
and transmitted via the retino-hypothalamic tract to the central clock located in the suprachiasmatic nucleus (SCN) entraining it to the external
light dark cycle(Gooley et al. 2001). Then, the SCN synchronizes all tissues and cells via humoral or neural signals maintaining coordination with
each other. Besides this synchronization, each tissue and cell has its own molecular clock, the peripheral clocks. Zeitgebers other than light, such
as food, temperature or social cues, can entrain/synchronize or strenghten the robustness of entrainment/synchronization of both the SCN and
peripheral clocks. This will result in the temporal organization of the many functions and behaviours that oscillate daily in most organisms on
the planet
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part of the positive arm of the loop. The CLOCK/
BMAL1 heterodimer binds to E-box sequences in the
promoters of the clock controlled genes regulating
the timing of their expression around 24-h. CLOCK/
BMAL1 also regulate the transcription of the negative
components of the loop that will repress their own
activity thereby closing the feedback loop, e.g., Period
(Per1, Per2, Per3) and Cryptochrome (Cry1, Cry2).
PER and CRY proteins heterodimerize and are phos-
phorylated by CASEIN KINASES 1 δ and ε (CK1δ
and CK1ε) which targets them for translocating back
into the nucleus where they directly bind to the
BMAL1/CLOCK complex, disrupting it and repressing
its actions. E3 ligase complexes will then target PER/
CRY for ubiquitylation which will lead to degradation
by the proteasome. As PER/CRY are degraded and
their levels decline, repression of BMAL1/CLOCK will
decrease and a new cycle will start. ROR-α and REV-
ERB-α proteins conform a second adjoining loop
binding to ROREs motifs found on the promoter ofBmal1 activating or repressing its transcription re-
spectively. What distinguishes the circadian clock
feedback loop from any other feedback loops is that
it takes about 24 h to be completed. This is achieved
through, for example, protein phosphorylation, ubiqui-
tylation, or SUMOylation that will tag proteins for
e.g. trafficking or degradation creating delays in the
24 h feedback loops.
Importantly, the transcription of about 2-10% of mam-
malian genes, from different murine and human tissues
or cells, are regulated by the molecular circadian clock
(and these include genes related to immune response
pathways as well as genes associated with inflammatory
lung diseases (see examples and reviews (Partch et al.
2014; Logan and Sarkar 2012; Oishi et al. 2003; Suku-
maran et al. 2011; Zhang et al. 2014a; Möller-Levet et al.
2013a; Akhtar 2002)). The percentage of proteins oscil-
lating in mammalian tissues are as high as 20%(Mauvoisin
et al. 2014; Reddy et al. 2006; Deery et al. 2009). This sug-
gests that not only transcription but other mechanisms
such as post-transcription, translation, post-translational
Fig. 2 Scheme representing the same mammalian cell, e.g. SCN cell, showing the molecular circadian clock sequence of events that under normal
entrainment conditions in nature, lasts 24 h.① CLOCK and BMAL1 proteins form a heterodimer which activates the transcription of genes encoding
other core components of the loop: e.g. Cryptochrome (Cry1 and Cry2), Period (Per1 and Per2), Nr1d1 (REV-ERB-α protein) or Ror-α. CLOCK and BMAL1
also regulate the transcription of the so-called clock controlled genes. Among these genes there are key factors in processes intimately related to
immune response.② Cry and Per mRNAs are translated into CRY and PER proteins with levels increasing during the night and form a heterodimer.
③CK1δ and CK1ε phosphorilate CRY and PER proteins allowing their translocation into the nucleus. ④ In the nucleus, the CRY/PER heterodimer
represses the BMAL1/CLOCK activity thereby inhibiting their own transcription.⑤ CRY and PER proteins are ubiquinated leading to their degradation
via the 26S proteosome. ⑥ CRY and PER levels decrease and with it their repression over BMAL1/CLOCK, allowing for a new cycle to start again and
the completion of the 24-h feedback loop. BMAL1/CLOCK also regulate the expression of the nuclear receptors Nr1d1 (⑦ REV-ERB-α protein) and Ror-α
(⑧ ROR-α protein) which will, in turn, repress or activate Bmal1 transcription
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dian patterns of behaviour, physiology and metabolism.
There is a circadian variation in immune function
The immune system has as a primary function to protect
against potentially harmful foreign bodies and disease.
The innate component of the immune system comprises
skin, all mucosal membranes, phagocytic cells (mono-
cytes, neutrophils, eosinophils, macrophages and baso-
philes) and natural killer T-cells (NK). It is considered a
first line of defence against foreign bodies and it also has
a critical role in the activation and regulation of adaptive
immunity (Iwasaki and Medzhitov 2015). This compo-
nent is semi-specific, non-adaptable, non-plastic and has
no ‘memory’. In contrast, the adaptive component of
immunity comprising B and T lymphocytes are adapt-
able, plastic and have ‘memory’. Immune cells of both
innate and adaptive immunity become activated and are
recruited to sites of infection or injury in the process of
inflammation (Riera Romo et al. 2016; Bennett et al.
2017; Ward and Rosenthal 2014). Although beneficial,
this inflammatory response can become over expressedleading to diseases and autoimmune disorders (Barnes
2008; Lien et al. 2012; Rose 2016).
Many cells and tissues of the immune system have been
shown to have clocks that regulate many of their
functions. In mammals, circadian clock genes oscillate in
the spleen, lymph nodes, thymus, jejunum, macrophages,
NK cells and CD4+ T cells (Keller et al. 2009; Bollinger
et al. 2011; Alvarez and Sehgal 2005; Froy and Chapnik
2007; Arjona and Sarkar 2005; Arjona and Sarkar 2006).
In fact, about 8% of the expressed genes in mice peritoneal
macrophages show circadian variation, including genes
involved in the regulation of pathogen recognition and
cytokine secretion (Keller et al. 2009). A recent microarray
study on the human blood transcriptome from sampled
around the clock shows that the number of oscillating
transcripts decreases and other genes are either up-, or
down-regulated when subjects are sleep deprived, and
genes associated with immune system amongst the most
affected genes (Möller-Levet et al. 2013b). Whilst this
suggests variations throughout the day in immune
function, acute responses to infection or response to
allergen exposure, future work is still needed to confirm a
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the clock mechanism and functional outcomes.
It has been known since the 1960s-70s that the
mortality rate of mice exposed to the bacterial endotoxin
lipopolysaccharide (LPS) greatly varies depending on
time of exposure (Halberg et al. 1960; Shackelford and
Feigin 1973; Feigin et al. 1969; Feigin et al. 1972). In
mice, a LPS challenge given at the end of the rest time
results in a mortality rate of 80%. When the challenge is
given in the middle of the active time the mortality rate
is only 20%(Halberg et al. 1960). Similarly, bacterial
infection has been shown to lead to higher mortality
when initiated during the rest period (Shackelford and
Feigin 1973). More recently, these results were confirmed
and extended showing that exposing mice to LPS at the
end of their rest period or beginning of the active period
resulted in a stronger cytokine response and NF-κB
activation compared with LPS exposure starting during
the active period or beginning of the rest period
(Marpegan et al. 2009; Gibbs et al. 2012; Nguyen et al.
2013; Spengler et al. 2012). Similar results have been
obtained in humans using the LPS challenge both in vivo
injecting LPS to healthy volunteers (Alamili et al. 2014)
and in vitro exposing blood samples obtained at different
times of the day from volunteers to LPS (Petrovsky et al.
1998; Rahman et al. 2015). The greatest response of the
immune system in terms of cytokine release occurs during
the rest and early active periods. However, this also
implies that the risk of immune-related illnesses, such as,
sepsis, allergies and uncontrolled immune reactions are
more likely to occur during the late rest period and early
active period.
Allergic reactions are initiated with antigen specific
IgE production and fixation of IgE to FcεRI receptors on
mast cells and basophils (Stone et al. 2010). Importantly
mast cells, eosinophils and basophils display circadian
oscillations of clock gene expression as well as circadian
gene expression and release of their mediators following
IgE-mediated activation (Baumann et al. 2013; Wang
et al. 2011; Ando et al. 2015; Baumann et al. 2015).
Several recent studies have shown that the circadian
clock regulated the daily rhythms in IgE/mast cell-
mediated allergic reactions. For example, Per2 mutant
mice have a decreased sensitivity to the corticosteroid
dexamethasone inhibition of the IgE-mediated degranu-
lation in bone marrow-derived mast cells (Nakamura
et al. 2011). Furthermore, anaphylactic reactions to an
allergen challenge display a time of day dependent vari-
ation in wild-type mice which disappears in Per2 mutant
mice exhibiting a strong reaction at all times throughout
the cycle (Nakamura et al. 2011). This could be due to
the disrupted circadian clock that specifically results
from the Per2 mutation (Spoelstra et al. 2014; Albrecht
et al. 2001; Chong et al. 2012; Xu et al. 2007)compromising the mice’s response to dexamethasone
as well as to an allergen challenge and its consequent
anaphylactic reaction. Another possibility is that PER2
protein has a clock-independent role in allergic reac-
tions as most clock proteins have in different pro-
cesses and pathways (Yu and Weaver 2011). The
authors hypothesized that Per2 could be regulating
the rhythmic secretion of glucocorticoids or gating
the glucocorticoid responses of mast cells to specific
times of the day. It could also be a combination of
clock-dependent and, −independent roles. Loss of
clock function due to other factors also leads to dis-
rupted responses to allergic reactions. For example,
Clock gene mutation in mast cells leads to disruption
of temporal variations in IgE mediated degranulation
in mast cells associated with loss of temporal regula-
tion of FcεRI expression and signalling (Nakamura
et al. 2014). Collectively, these studies suggest that
not only proper functioning of the immune system is
regulated by circadian clocks but also allergies have a
strong circadian component.
In turn, inflammation can also affect the circadian
clock and the pathways it regulates such as metabolism
and sleep-wake cycle (Bellet et al. 2013; Jewett and
Krueger 2012; Lundkvist et al. 2002; Lundkvist et al.
2010). The circadian firing rhythms of the SCN neurons
as well clock gene expression in the SCN is differentially
affected by various cytokines, i.e. IFN-γ, TNF-α, IFN-α
as well as the LPS challenge (Lundkvist et al. 2002; Kwak
et al. 2008; Nygård et al. 2009; Okada et al. 2008). Fur-
thermore, the effect of cytokines or LPS on clock gene
expression in the SCN and peripheral clocks of rodents
such as liver, heart or spleen, temperature or locomotor
activity will vary depending on the time of day at which
cytokines are administered (Duhart et al. 2013; Ohdo
et al. 2001; Koyanagi and Ohdo 2002; Yamamura et al.
2010; Westfall et al. 2013; Marpegán et al. 2005; Leone
et al. 2012; Boggio et al. 2003). Similarly in humans, LPS
injection causes a suppression of clock genes e.g. Clock,
Cry1,2, Per1,2,3, Csnk1ε, Ror-α and Rev.-erb-α in periph-
eral blood lymphocytes, neutrophils and monocytes
(Haimovich et al. 2010).
Marpegan and colleagues suggested that immune
responses may be acting as a synchronizing signal for
the clock in a similar way to light that advances and
delays circadian rhythms depending on time of day at
which they administered (Marpegán et al. 2005). Im-
mune responses could be acting as disrupting circadian
clock signals instead. Chronic inflammation achieved by
weekly injecting LPS to mice for 2 months leads to a de-
creased response of the SCN to light 7 days after the last
LPS injection; however, the SCN response to light was
restored 30 days after the last LPS injection (Palomba
and Bentivoglio 2008).
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system interacts with the molecular clock there are a
few of studies so far. Cavadini and colleagues showed
that TNF-α inhibits CLOCK-BMAL1 function by
interfering with E-box mediated transcription leading
to downregulation of expression of clock-controlled
genes with E-boxes in their promotor (Cavadini et al.
2007). Petrzilka and colleagues extended this work
and showed that TNF-α requires p38 mitogen-
activated protein kinases (MAPK) and/or calcium
signalling to upregulate expression of several core
clock genes but it can downregulate Dbp (clock
controlled gene) expression independently from p38
but requires calcium signalling (Petrzilka et al. 2009).
And Bellet and co-workers showed that the RelB
subunit of NF-kB interacts with BMAL1 protein and
represses the circadian expression of Dbp (Bellet et al.
2012). Overall, these studies provide clues to under-
stand the cross-talk between the circadian and
immune systems in inflammatory diseases. Further
research should be directed at understanding the
potential mechanisms by which the immune system
gives time cues to the circadian system, both in
health and in acute and in chronic inflammation.The central clock regulates immune function
The central clock, located in the SCN, is thought to
regulate aspects of immune responses. For instance, the
SCN has been shown to regulate clock gene expression,
oscillations in cytokines and cytosolic factors in NK cells
and splenocytes in rats via the noradrenergic system
(Logan et al. 2011). A lesion in the SCN leads to loss of
the time of day dependence in passive systemic anaphyl-
actic reaction in mice as well as loss of daily variations
of cytokines (Nakamura et al. 2014). It has been shown
that conditional ablation of Bmal1 in T and B cells does
not affect cell differentiation or their function suggesting
a regulatory role of the central clock since circadian
gating of IL-2 is preserved in Bmal1-deficient cells
(Hemmers and Rudensky 2015).
The circadian regulation of the immune response is
likely to be an integration of signals from the central
clock and the peripheral clocks found in immune cells
and organs as well as sites of infection. A very good
example of this integration is the recent work by Gibbs
and colleagues (Gibbs et al. 2014). They showed that the
inflammatory response of the mouse lung to LPS has a
daily rhythm peaking in the rest period which is
regulated by both peripheral and central clocks. Thus,
both the epithelial club cells (Clara) clock and the
central clock through systemic glucocorticoid signals of
adrenal origin, regulate the circadian oscillation of the
CXCL5 chemokine which, in turn, drives the circadianoscillation of neutrophil recruitment to the lung. Disrup-
tion of the central or Clara cell clocks, i.e. ablation of
Bmal1 in the Clara cells or adrenalectomy, leads to the
disruption of circadian oscillation of CXCL5 and, in
consequence, of the neutrophil recruitment to the lung.
These experiments demonstrate the importance of
central-peripheral clock interaction in mediating lung
immune responses.
As for cortisol and melatonin, outputs of the central
clock, control the circadian oscillation of the number of
circulating T cells in humans (Dimitrov et al. 2009;
Besedovsky et al. 2014). Melatonin regulates daily rhythms
of core clock gene transcription factors, Bmal1 and Per1
expression in the spleen and a pinealectomy (the surgical
removal of the pineal gland which produces melatonin)
abolishes these rhythms (Prendergast et al. 2013). Mela-
tonin is thought to have an immuno-modulatory role that
can either be pro or anti-inflammatory however the mech-
anism is still unclear. Different studies showing the actions
of endogenous and exogenous melatonin on the immune
system have been reviewed elsewhere (Carrillo-Vico et al.
2005; Carrillo-Vico et al. 2013; Ren et al. 2017). Neverthe-
less it is worth mentioning the review by Carrillo-Vico
and co-authors suggesting that melatonin may act as an
immune buffer, whereby it may act as an immune stimu-
lant under immune suppressive conditions and as an anti-
inflammatory agent under conditions of exacerbated
inflammation (Carrillo-Vico et al. 2013). If true, then
interest in the potential for melatonin as a therapeutic
with immune-modulatory properties will significantly
increase in the future.
Peripheral clocks regulate immune function
Many cells and organs that are part of the immune
system have been shown to display circadian oscillations
in clock gene expression and function. Table 1 shows
examples of immune system components displaying
oscillations in number of cells and/or functionality. Toll-
like receptors (TLRs) are proteins expressed on the
surface of many cells and within endosomes and play a
role in pathogen recognition and consequent activation
of the innate immune system. The expression levels of
TLRs display significant circadian oscillations in the
mouse jejunum (Froy and Chapnik 2007). The levels of
TLRs start to rise during the second part of the active
phase and peak during the rest period which is probably
when unwanted bacteria have reached the jejunum.
Silver and colleagues demonstrated in mice that the
expression of TLR9 in macrophages and B cells display
circadian rhythmicity (Silver et al. 2012). The TLR9
circadian rhythm has functional consequences. For
example, the time of day at which sepsis was experimen-
tally induced in mice determines sepsis severity and
mortality. This also coincides with the time of day when
Table 1 Examples of circadian rhythms in the immune system and the correspondent peaks and troughs of these oscillations
Organism Oscillating component Peak Trough Ref.
Mouse Number of Ly6Chi monocyte in blood and spleen ZT4-ZT8 ZT12-ZT24 (Nguyen et al. 2013)
Mouse Circulating total leukocyte counts ZT5 ZT13 (Scheiermann et al. 2012)
Mouse Circulating HSCs and their progenitors ZT5 ZT17 (Mendez-Ferrer et al. 2008)
Mouse Number of LSK cells per ml of blood ZT5 ZT13 (Mendez-Ferrer et al. 2008;
Lucas et al. 2008)
Mouse Activation of NF-κB ZT6 ZT18 (Spengler et al. 2012)
Mouse TNF-α and IL-6 secreted by spleens harvested around the clock
and stimulated with LPS
CT8 CT20 (TNFα)
CT16 (IL-6)
(Keller et al. 2009)
Mouse Abundance of B cells and macrophages in the spleen CT8 CT16 (Keller et al. 2009)
Mouse Cytokine responses to LPS IL-1β, IL-6, MCP-1 and MIP1alpha ZT11 ZT19 (Marpegan et al. 2009)
Mouse TLR9 mRNA in macrophages ZT11 ZT3 (Silver et al. 2012)
Mouse Cytokine responses to LPS: IL-6, IL-12, CCL5, CXCL1 and CCL2 ZT12 ZT0 (Gibbs et al. 2012)
Mouse Recruitment of leukocytes from the blood to tissues ZT13 ZT5 (Scheiermann et al. 2012)
Mouse ICAM1 protein abundance in muscle ZT13 ZT5 (Scheiermann et al. 2012)
Mouse Ccl2 mRNA abundance in cremasteric endothelial cells ZT13 ZT1 (Scheiermann et al. 2012)
Mouse CXCR4 expression in bone marrow LSK cells ZT13 ZT5 (Lucas et al. 2008)
Mouse TLR9 mRNA and protein abundance in the spleen ZT19 ZT7 (Silver et al. 2012)
Mouse Phagocytic activity of neutrophils ZT20 ZT8 (Hriscu 2004)
Mouse CXCL12 content in bone marrow extracellular fluids ZT21 ZT9 (Mendez-Ferrer et al. 2008)
Human Counts of peripheral monocytes 12:00 am 8:00 am (Born et al. 1997)
Human Counts of peripheral Lymphocytes, B-cells, T-cells, T-helper,
T-suppressor
2:00 am-3:00 am 11:00 am (Born et al. 1997)
Human Circulating eosinophils 4:00 am 12:00 pm (Haus and Smolensky 1999)
Human Circulating lymphocytes 12:00 am-4:00 am 8:00 am (Haus and Smolensky 1999)
Human Counts of peripheral NK 11:00 am-6:00 pm 2:00 am (Born et al. 1997)
Human CD4+ T helper, CD8+ cytotoxic T cells: naïve, central memory,
effector memory
1:31 pm-2:41 pm 2:00 pm (Dimitrov et al. 2009)
Human Effector CD8+ T cells 3:34 pm 3:00 am (Dimitrov et al. 2009)
Human Circulating monocytes 8:00 pm 8 am (Haus and Smolensky 1999)
Human HSC / progenitor cells in peripheral blood 8:00 pm 8:00 am (Lucas et al. 2008)
Human Circulating neutrophils 8:00 pm 8:00 am (Haus and Smolensky 1999)
Note that in animal research, time of day does not correspond to “clock-time” but it is instead relative to the time of day at which lights are turned on and off in
the animal facilities. Thus, ZT stands for Zeitgeber Time and ZT0 corresponds to the time of day when lights are turned-on and if mice are in a LD12:12 (12 h of
light and 12 h of dark) ZT12 corresponds to time of day when lights are turned-off. If animals are in constant conditions (normally constant dark, but it could be
constant light) then CT is used instead of ZT. CT stands for Circadian Time and CT0 corresponds to the time of day when animals start their resting time (as if
lights were turned-on) and CT12 corresponds to the time of day when their activity time starts (as if lights were turned off). In the human studies that we have
listed here, the authors provide “clock-times”
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period (Silver et al. 2012). Another example of circadian
variation in innate immunity occurs in the spleen and
NK cells of rats where transcripts of IFN-γ, granzyme
B, perforin and TNF-α display circadian oscillations
peaking at the end of the active phase and beginning
of rest phase coinciding with the cytolytic activity of
splenic NK cells (Arjona and Sarkar 2005; Arjona
and Sarkar 2006; Arjona et al. 2004). Adaptive im-
mune responses are also circadian regulated. The cir-
cadian clock in lymphocytes regulates their migration
through lymph nodes which show a daily variationpeaking at the beginning of the active phase in mice
with a trough at the end of the active phase. Genetic
disruption of T-cell clocks abolishes this rhythm
(Druzd et al. 2017). The authors argue that the time
of day of generation of the adaptive response as well
as the numbers of cells present in the lymph node,
are crucial in the regulation of the strength of the
adaptive immune responses (Druzd et al. 2017; Moon
et al. 2007). This idea is in agreement with Silver
and colleagues work who showed that vaccinating
mice with a TLR9 ligand as the adjuvant at the time
of day when TLR9 was more responsive (active
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4 weeks later compared to animals vaccinated at
other times (Silver et al. 2012).
It is interesting that the timing of peaks and troughs of
function or number of immune cells do not necessarily
coincide despite all components being part of the coor-
dinated immune response. A plausible hypothesis to
explain the function of differentially gating the timing of
different immune system components may be to avoid an
excessive simultaneous immune response to a threat that
may prove detrimental for the organism (Man et al. 2016).
On the other hand, hosts and parasites have evolved to
exert selective pressure onto the other whilst the environ-
ment exerts pressure on both (Martinez-Bakker and Helm
2015). The host coordinate immune responses to times of
day when exposure to threats are more likely to happen.
Bacteria may, in turn, increase growth dependent on the
host’s circadian rhythms (Bellet et al. 2013). Bellet and
colleagues infected mice with Salmonella enterica serovar
Typhimurium at two timepoints, 4 h after beginning of
active time and 4 h after resting time, and showed bacteria
clearance 72 h after infection was greater 4 h after begin-
ning of active time. The authors subsequently found that
the antimicrobial peptide lipocalin-2 levels in the gut was
higher during the day than during the night, which
suppressed the growth of resident microbiota during the
day. However, Salmonella is lipocalin-2 resistant allowing
a window for Salmonella to increase outgrowth during the
day when there is less competition with other microorgan-
isms compared to night time (Bellet et al. 2013). Thus,
despite the lack of proof that Salmonella has its own circa-
dian clock it still takes advantage of circadian variations in
levels of lipocalin-2 in its host.
In conclusion and as illustrated in Fig. 1, the coordin-
ation of the immune system oscillatory function is regu-
lated at different levels, the master clock level as well as
peripheral clock levels. This secures an optimization of
the timing of the immune response around the clock so
that it is most effective against threads to the organism
and causes the least damage to the host organism.
Dysregulation of the clock will cause disease as we will
describe in the next section.Dysregulation of the clock leads to a
dysregulated immune response
Numerous experiments have shown that altering the
period and/or amplitude of rhythm of the master clock in
the SCN and/or peripheral clocks in organs such as the
liver and lungs, result in dysregulation of the immune re-
sponse. This has been demonstrated under conditions of
shift- work where feeding/fasting and sleep/wake cycles
are uncoupled from the master and peripheral clocks, with
lesion of the SCN (which destroys the master clock), withaging and with the generation of mutant mice or knock-
out/knock-down mice for clock proteins involved in pro
and anti-inflammatory responses.
Pro-inflammation
In rodents exposed to simulated shift-work with work
and feeding during the day, which corresponds to their
usual rest and fasting period, and inactivity and fasting
at night (usual active feeding period), there is an uncoor-
dinated inflammatory response to LPS challenge, result-
ing in elevated cytokine levels and increased mortality
(Castanon-Cervantes et al. 2010; Adams et al. 2013;
Guerrero-Vargas et al. 2015). Interestingly, if feeding
time is restricted to the night time and normal active
phase then the immune response is not dysregulated
when undergoing LPS challenge. The TNF-α and IL-6
inflammatory cytokine levels remain at a similar level to
control (ad libitum feeding and activity) rats. In contrast,
when animals not subjected to simulated shift-work are
restricted to feeding in the day time (the normal resting
period), the immune response is also dysregulated with
elevated TNF-α and IL-6 levels (Guerrero-Vargas et al.
2015). These data suggest that feeding is a stronger
Zeitgeber than light in keeping the immune system
synchronized and undisturbed. In this context, the gut
microbiome is increasingly being implicated in playing a
role in chronic inflammation. It has recently been
proposed that a desynchronization between sleep, circa-
dian and feeding/fasting cycles, such as that which occurs
during shift-work, may promote alterations in gut micro-
biota leading to chronic inflammation (Reynolds et al.
2017). This research, however, is relatively new and re-
quires further extensive examination (Phillips and Comas
2017). A different method to induce circadian disruption
is by lesion of the SCN master clock (Moore and Eichler
1972; Stephan and Zucker 1972). Similar to simulated
shift-work, bilateral lesions of the SCN in rats leads to a
dysregulated immune response with significantly higher
levels of cytokines after exposure to LPS compared to
controls (Guerrero-Vargas et al. 2014). Aging has also
been shown in rats to dysregulate the circadian clock by
decreasing the amplitudes of oscillation of clock genes
and cytokine mRNA. This in turn resulted in a chronic
state of inflammation with loss of the inflammatory re-
sponse to an LPS challenge (Fonken et al. 2016). Circadian
disruption can also be induced by mutation or knocking
down different clock genes. This has resulted in decreased
levels of cytokines suggesting a pro-inflammatory role for
these clock genes. For example, mutation or knocking
down Per2 resulted in decreased levels of granzyme B
(Arjona and Sarkar 2006), perforin proteins (Arjona and
Sarkar 2006), IFN-γ (Arjona and Sarkar 2006; Arjona and
Dk 2006; Liu et al. 2006) and IL-1β (Liu et al. 2006). In
accordance with these studies, Per2 mutant mice are
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types (Liu et al. 2006). A reduction of cytokine
production (in response to the LPS challenge or
Salmonella Typhimurium infection) is observed in
macrophages from Clock mutant mice (Bellet et al.
2013). This is in agreement with the finding that
CLOCK protein activates the NF-κB pathway leading
to upregulation of cytokines (Spengler et al. 2012).
Anti-inflammation
When a different set of clock genes are compromised
then inflammation increases suggesting that other clock
proteins have anti-inflammatory roles. This has been
shown with deletion of Ror-α in mice which leads to
abnormal immune responses such as hyper responsive
macrophages producing higher levels of cytokines in
bronchoalveolar lavage fluids after LPS challenge
(Sidman et al. 1962; Kopmels et al. 1990; Trenkner and
Hoffmann 1966; Stapleton et al. 2005; Dzhagalov et al.
2004). Macrophages from Rev.-erb-α−/− mice and from
LysM-Bmal−/− mice (mice that lack Bmal1 in their macro-
phages, monocytes and neutrophils) show loss of
circadian gating and constitutively elevated levels of IL-6
in response to the LPS challenge (Gibbs et al. 2012). Two
more studies show the important role of BMAL1 protein
in inflammation. Bmal1−/−Lys-MCre mice are more
susceptible to LPS challenge compared to wild type mice
with decreased survival. Interestingly, deletion of MiR-155
which represses Bmal1 leads to a reduced inflammatory
response to the LPS challenge (Curtis et al. 2015). Thus,
this work suggests that Bmal1 has an important anti-
inflammatory role which is relevant not only at the protein
level but also at the miRNA regulation level. Knocking
down or silencing Cry1 and Cry2 also leads to increased
inflammation (Narasimamurthy et al. 2012; Hoffman et al.
2009). Whether we can assign definitive anti or pro-
inflammatory roles to specific clock genes still requires
more work. The effects observed so far for each clock
protein may be cell-specific, immune function-specific
(e.g. innate vs adaptive) or even species specific.
These studies highlight the need for further research
exploring the mechanistic links between circadian clock
function and inflammation. However, the available data
does provide a framework for continuing translational
research in chronotherapy to more effectively manage
acute and chronic inflammation.
Circadian rhythms in respiratory inflammatory
disease
It is quite clear that the stronger responses of the
immune system occur from the second half of the rest
time and the first hours of the activity time. Thus, in
humans, immune responses are stronger in the second
half of the night and early morning hours. These are thetimes when inflammation is exacerbated and symptoms
and mortality rates are highest (Buttgereit et al. 2015;
Smolensky et al. 2015). In parallel, timed therapies that
decrease inflammation during the night and early
morning hours has proven to be more successful than
untimed therapy (Smolensky et al. 2007; Buttgereit et al.
2015; Smolensky et al. 2015). Below we discuss these
concepts in the context of several common respiratory
inflammatory diseases.
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD), is the
fourth highest cause of death globally (GOLD, 2016).
Like other chronic diseases, it is largely caused by
preventable risk factors (cigarette smoking and noxious
air-borne particles). COPD is a systemic disease with
significant extrapulmonary effects that contribute to
morbidity and mortality. Its pulmonary component is
characterised by airflow limitation which is not fully
reversible and is usually progressive and associated with
an abnormal inflammatory response of the lung to
noxious particles or gases (GOLD, 2016). A patient
suffering from COPD may have persistent inflammation,
increased mucus secretion (chronic bronchitis) and
narrowing and destruction of their small airways (small
airways disease) and/ or they may have destruction of
the lung alveoli resulting in emphysema. COPD symp-
toms vary throughout the day. While some patients
report worsening of their symptoms (cough, shortness of
breath and phlegm) in the early morning upon awaken-
ing, others complain of nocturnal symptoms, most
commonly wheezing, shortness of breath and cough
which also cause sleep disruption (Kessler et al. 2011;
Price et al. 2013; Lange et al. 2014; Agusti et al. 2011;
Stephenson et al. 2015; Jen et al. 2016; Partridge et al.
2009; Espinosa de los Monteros et al. 2012; Kuyucu
et al. 2011; Kim et al. 2012; Decramer et al. 2013; Roche
et al. 2013; Roche et al. 2013; Miravitlles et al. 2014; Tsai
et al. 2007).
Lung cells have their own molecular circadian clocks
that coordinate tissue-specific functions and responses
to environmental stimuli (Sukumaran et al. 2011; Gibbs
et al. 2009; Oishi et al. 1998). This results in circadian
oscillations in many common lung function indices (e.g.
forced vital capacity (FVC), forced expiratory volume in
1 s (FEV1) and peak expiratory flow (Agusti et al. 2011;
Spengler and Shea 2000)). These normal circadian oscil-
lations in airway calibre may be partly responsible for
nocturnal COPD exacerbations and worsening hypoxia
(Agusti et al. 2011; Tsai et al. 2007) however, the impact
appears to be much greater in asthmatics (Tsai et al.
2007; Brenner et al. 2001), perhaps because of airway
hyperresponsiveness (the ability of airways to contract
too much and too easily). Although the underlying basis
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circadian variations in airway calibre could be due to
changes in the contractile properties of airway smooth
muscle, inflammation (Kraft et al. 1996), neural activity
or changes in lung mechanics during sleep (Irvin et al.
2000). Given that several studies have found that
critically ill COPD patients are more likely to die at
night and that this is attributable to COPD exacerba-
tions, there is a clear role of the clock in adverse
outcomes (Tsai et al. 2007; Martin 1990; Petty 1988;
McNicholas and Fitzgerald 1984; Tirlapur 1984; Kimura
et al. 1998; Chaouat et al. 2001). Nevertheless early
morning symptoms and night time symptoms remain
one of the adverse outcomes of COPD, particularly in
more severe cases (Partridge et al. 2009). Importantly, a
recent study showed that COPD patients that report
both or either nocturnal or early morning symptoms
have poorer health compared with patients who do not
have a worsening of symptoms at specific times of day
(Stephenson et al. 2015). This could potentially be used
as a biomarker of disease status and there is scope for
developing chronotherapeutic approaches for these
patients to cover the times of day with worsening symp-
toms. Very little is known about circadian changes in lung
function or disease activity in COPD or why nocturnal
symptoms are associated with poorer outcomes. Perhaps
research in this area will translate to future clinical
benefit.
Additionally, and in the context of this review, several
studies have found a potential mechanism connecting
disruption of lungs circadian clock, inflammation and
COPD (Yao et al. 2015; Hwang et al. 2014; Rajendra-
sozhan et al. 2008). Importantly, levels of the deacety-
lase SIRT1 are reduced in COPD patients, as well as in
smokers and in mice exposed to cigarette smoke (Yao
et al. 2015; Hwang et al. 2014). Furthermore, SIRT1
regulates both central and peripheral circadian clocks
(Masri and Sassone-Corsi 2014). A decrease in SIRT1
levels in COPD patients, smokers and mice exposed to
cigarette smoke results in increased acetylation of
BMAL1 leading to an increased BMAL1 protein deg-
radation and, in consequence, to a molecular clock dys-
regulation and an increased inflammatory response is
observed (Yao et al. 2015; Hwang et al. 2014). To
confirm the role of BMAL1 in lung inflammation,
Hwang and colleagues studied mice carrying a targeted
deletion of Bmal1 in lung epithelium and they observed
that these mice also suffer from increased inflammatory
response to cigarette smoke which is not reduced when
mice are treated with a SIRT1 activator (Hwang et al.
2014). The authors concluded that both BMAL1 protein
as well as its regulation by SIRT1 must have a key role
in lung inflammation in COPD patients and smokers
(Hwang et al. 2014).Apart from cigarette smoke (Yao et al. 2015; Hwang
et al. 2014; Vasu et al. 2009; Gebel et al. 2006), other en-
vironmental factors such as respiratory infections or
even chronic jet-lag can lead to dysregulation of the lung
circadian clock leading to increased lung inflammation.
Sundar and co-workers showed mice with chronic
exposure to cigarette smoke combined with infection of
influenza A virus altered lung clock gene expression and
increased lung inflammation as well as emphysema. The
same experiment performed on Bmal1 Knockout mice
resulted in increased lung inflammation and pulmonary
fibrosis (Sundar et al. 2015). Disruption of circadian
rhythms in mice using a chronic jet-lag protocol for
4 weeks leads to disruption in lung physiology and lung
clock gene expression (Hadden et al. 2012). Evidence
from a study which investigated the effect of chronic
exposure to real-life ambient air particles showed that
pollution leads to circadian clock gene expression
disruption in the lungs of rats as well as increased lung
and systemic inflammation and oxidative stress (Song
et al. 2017). These animals were housed in the Haidian
district of Beijing which has characteristically high levels
of polluted air due to heavy traffic.
The specific pathways regulated by the circadian clock
that influence COPD are not clear yet. However, several
recent publications have demonstrated that if the circa-
dian clock controlled expression of genes is unregulated,
it may lead to pulmonary disease. Disruption of the
circadian clocks regulation of Nrf2 expression in mouse
lungs leads to chronic pulmonary diseases including
COPD, asthma, idiopathic pulmonary fibrosis and cancer
(Pekovic-Vaughan et al. 2014). Sukumaran and co-
workers showed in rats lungs that genes associated with
COPD display circadian oscillations and that some of
these oscillating genes are potential COPD drug targets
i.e. Myristoylated Ala-rich PKC substrate (Marcks) and
Adrenergic β2 receptor (Adrb2) (Sukumaran et al. 2011).
Similarly, Zhang and colleagues listed drugs that are
indicated to treat COPD and that target genes that oscil-
late (Zhang et al. 2014b). Disentangling the molecular
pathways that contribute to emphysema and bronchitis
in COPD patients regulated by the circadian clock will
permit the development of novel chronotherapeutic
approaches.
Allergic rhinitis
Allergic rhinitis (AR) is increasing worldwide with
current prevalence rates of between 10% and 30%. The
prevalence is particularly high in developed countries
(Bousquet et al. 2008; Mullol et al. 2008). AR is an
immune system-mediated upper airway hypersensitivity
to environmental allergens. It is characterized by respira-
tory tissue inflammation, mucus gland hyperactivation
and blood vessel dilation. In people suffering from AR,
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are mediated by a series of inflammatory cells and medi-
ators. The early phase occurs immediately after allergen
exposure and the late phase develops 8 to 12 h after al-
lergen exposure. The most common symptoms of AR
are sneezing, itching, rhinorrhoea, nasal congestion, and
post-nasal drip. The symptoms of the late phase are
similar to the early phase, but with more severe conges-
tion (Stull et al. 2009; Hansen et al. 2004).
A daily rhythm in allergic symptoms has been known
since the 1960s (Reinberg et al. 1963; Reinberg et al.
1969). Symptoms often intensify overnight and are worst
upon wakening, displaying a “morning attack” (Smolensky
et al. 2007; Smolensky et al. 2015; Long 2007; Gelfand
2004; Smolensky et al. 1995; Reinberg et al. 1988). Due to
the time at which symptoms intensify, AR symptoms often
disrupt sleep (Craig et al. 2008; González-Núñez et al.
2013; Santos et al. 2006). This may lead to daytime fatigue,
interfering with daily activities, including the capability to
work or study and overall quality of life (Stull et al. 2009;
González-Núñez et al. 2013; Santos et al. 2006; Bousquet
et al. 2013; Walker et al. 2007; de la Hoz et al. 2012; Blanc
et al. 2001). Work and school absenteeism and decreased
productivity at work due to AR are associated with sub-
stantial economic costs, ranging between 2 and 5 billion
US dollars (Blaiss 2010; Lamb et al. 2006; Roger et al.
2016). Importantly, the upper airway obstruction that
characterizes AR is a risk factor for sleep disordered
breathing events, such as apnoeas, hypopneas and snoring
in adults and children (Long 2007). AR patients have daily
rhythms of salivary melatonin that have a decreased
amplitude, baseline and peak levels, as well as lower
amplitude of salivary cortisol daily rhythm and delayed peak
compared to healthy controls (Fidan et al. 2013). The rea-
son for the lower robustness of these rhythms is unknown
but may be due to sleep disruption and/or as a conse-
quence of inflammation. It is also unclear if these disrupted
rhythms further worsen inflammation and allergy.
Mouse nasal mucosa has a functional circadian clock
and its response to glucocorticoids is dependent on the
time of day (Honma et al. 2015). This daily rhythm in
hypersensitivity to allergens contributes to the daily
rhythms observed in AR (Nakamura et al. 2011; Nakamura
et al. 2014; Nakamura et al. 2014; Nakamura et al. 2016).
For example in children exposed to an allergic challenge at
6 am, more nasal secretions are produced than when
exposed at 3 pm (Aoyagi et al. 1999). Furthermore, the
commonest allergen for patients suffering from AR is house
dust mite. The greatest allergen challenge occurs from the
bedding exposure to dust mite during time in bed during
the night which coincides with the worst time for the
circadian clock to deal with allergen challenge.
In the context of chronotherapy, Reinberg and
colleagues tested whether H1 receptor antagonists weremore effective at 7 am compared to 7 pm and found that
evening administration was more effective (Reinberg
1997). Importantly, whilst corticosteroid nasal sprays
have been shown to effectively treat allergic symptoms,
they also interfere with the nasal circadian clock. From a
mechanistic perspective, studies have shown that
endogenous glucocorticoids regulate clock gene expres-
sion by binding directly onto the promoter of clock
genes (Per1, Per2 and Rev.-erb-α) (Cheon et al. 2013;
Yamamoto et al. 2005) and that administration of
prednisolone induces Per1 expression, affecting normal
clock function (Fukuoka et al. 2005; Koyanagi et al.
2006). However, the disruption of clock function by
prednisolone can be reduced, simply by changing the
time of day at which it is administered (Koyanagi et al.
2006). Therefore, the questions arise, what is the best
chronotherapeutic strategy to maximise treatment effect-
iveness? And does it have to minimally disrupt the nasal
mucosa circadian clock? Based on their work in mice,
Honma and colleagues proposed that the best time to
administer intranasal corticosteroids to treat AR is when
they disrupt the nasal clock least, which corresponds to
early evening for humans (Honma et al. 2015). The
authors argued that this timing corresponds to the same
time at which aerosol corticosteroid is most efficient to
treat asthma and that repeated disruption of circadian
clocks leads to other health issues or worsens previous
conditions (Honma et al. 2015). Nakamura’s work, on
the other hand, suggested that the best time to treat
allergies was at the time the circadian clock was most
susceptible to be disrupted, which is during the night in
humans and during the day in mice (Nakamura et al.
2016). They showed that treating with dexamethasone at
a time of day that resulted in increasing PER2 levels and
reducing FcεRI signalling in mast cells or basophils
resulted in suppression of IgE mediated allergic reactions
in a mouse model of AR. Furthermore, dexamethasone
did not decrease the allergic reactions in both Clock-mu-
tated or Per2-mutated mast cells. They further hypothe-
sized that reduction of FcεRI signalling depends on
PER2 upregulation by glucocorticoids (Nakamura et al.
2016). Even though it appears as a very promising
chronotherapeutic approach it is important to under-
stand the long-term consequences of upregulating PER2
by glucocorticoids and thus disrupting the circadian
clock in a chronic disease such as AR. Understanding
the circadian patterns of allergic response and its regula-
tion by the central and peripheral clocks, specifically in
humans will enable discovery of preventive measures
which utilise chronotherapy to treat AR patients.
Asthma
Asthma is a chronic inflammatory disease of the lungs that
affects approximately 334 million people worldwide (Global
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hypersensitivity to environmental antigens which leads to
inflammation driven by IgE-dependent mechanisms, con-
striction and obstruction of the airways. However, non-
allergic asthma phenotypes are also common. Asthma
shares a lot of characteristics with allergic diseases, includ-
ing genetic risk factors (Bousquet et al. 2000). Asthma
episodes, as well as asthma exacerbations, are more
prone to happen during the night and early morning
compared to other times of the day both in adults
and in children (Smolensky et al. 2007; Reinberg
et al. 1988; Turner-Warwick 1988; Smolensky and
D’Alonzo 1997; Hoskyns et al. 1995; Jarjour 1999;
Bohadana et al. 2002; Litinski et al. 2009). One of the
first studies involving 3000 asthma patients found
that asthma episodes during washout from regular
maintenance asthma treatment occurred 70-fold more
frequently between 4 am and 5 am compared to
2 pm-3 pm (Dethlefsen and Repges 1985). Death
from severe asthma attacks is also known to mostly
occur during the night or early morning (Smolensky
and D’Alonzo 1997; Cochrane and Clark 1975).These
times coincide with the times at which lung function is
reduced and inflammation and airway hyperreactivity is
increased (Spengler and Shea 2000; Kraft et al. 1996;
Jarjour 1999; Martin et al. 1991; Hetzel and Clark 1980;
Gervais et al. 1977; Bonnet et al. 1991; Panzer et al. 2003;
Kelly et al. 2004).
Studies with asthmatics using sleep deprivation proto-
cols have shed some light on the partial contribution of
sleep and of circadian variation to airway calibre and
lung function. Ballard and colleagues studied pulmonary
function in asthmatic patients during a sleep deprived
night and a normal sleep night (Ballard et al. 1989).
They observed that lower airway resistance increases
during the night, regardless of whether asthmatic
patients sleep or not, but the rate of increase is two-fold
higher if patients are allowed to sleep compared to sleep
deprivation, implying that sleep itself increases lower
airway resistance. However, decrements in forced
expired volume in 1 s (FEV1) were not significantly
different between the sleeping night and the sleep
deprived night (Ballard et al. 1989). Using the same
protocol, another group found that in asthmatics,
nocturnal bronchoconstriction occurred both in the
sleep and sleep-deprived nights but the morning values
of peak expiratory flow (PEF) were higher after the
awake night and the absolute and percentage falls in PEF
were greater in the sleep night, suggesting the contribu-
tion of sleep to nocturnal bronchoconstriction (Catterall
et al. 1986). Furthermore, the amplitude of PEF variation
in asthmatics is greater compared to non-asthmatics,
indicating an exaggeration of daily variation in airway
calibre in asthmatics during the night (Hetzel and Clark1980). However, the Hetzel study showed that sleep
deprivation does not improve the overnight fall in PEF,
suggesting that it is the circadian variation in pulmonary
function, rather than sleep, causing the PEF fall in
asthmatics (Hetzel and Clark 1979). The overnight
decrease in PEF is related to greater severity of daytime
asthma (Martin et al. 1990). Similarly, the time of day at
which an asthmatic is undergoing an allergen challenge
will have an impact in the chances of developing a late
asthmatic response, being higher in the evening com-
pared to the morning (Mohiuddin and Martin 1990).
Nocturnal worsening of asthma has also been associ-
ated with nocturnal increases in lung inflammation. For
example, analysis of bronchoalveolar lavage fluid from
asthmatic patients showed that patients with nocturnal
asthma had higher leukocytes count, specifically eosino-
phils and neutrophils, at 4 am compared to 4 pm,
whereas in asthmatic patients without nocturnal
episodes, there was no difference between these two
time-points. When comparing both groups of patients,
there was a significant difference between them at 4 am
but not at 4 pm (Martin et al. 1991). Therefore, day time
leukocytes count were similar between groups but the
difference was attributable to the number of immune
cells found during the night. These results were
confirmed in other studies with a comparable protocol
looking at neutrophils, macrophages and CD4+ cells
(Kraft et al. 1996; Kraft et al. 1999) as well as when com-
paring non-asthmatic controls to nocturnal asthmatic
patients (Mackay et al. 1994; Oosterhoff et al. 1995).
Another study also showed a higher blood concentration
of eosinophils at 4 am compared to 4 pm in nocturnal
asthmatics (Calhoun et al. 1992). Furthermore, the night
fall in PEF was positively correlated with change in neu-
trophils and eosinophils, further indicating a relationship
between nocturnal inflammation and decline of pulmon-
ary function in nocturnal asthmatics (Martin et al.
1991). Another study investigated FEV1 and sputum
inflammatory cells in mild asthmatics at 4 pm and 7 am
resulting in similar findings to the previous studies, that
is, lower FEV1 at 7 am with higher numbers of sputum
inflammatory cells compared to 4 pm timepoint (Panzer
et al. 2003).
Studies on bronchial hyperreactivity in asthmatic
patients in the 1970s have also shown a clear daily
variation. Gervais and colleagues exposed asthmatic
patients to a bronchial challenge with house dust in an
otherwise allergen-shielded room. They measured airway
calibre using FEV1 15 min after house dust inhalation at
8 am, 3 pm, 7 pm and 11 pm and showed that the stron-
gest response occurred at 11 pm whilst the weakest
response occurred at 8 am (Gervais et al. 1977). In
addition, the effects of histamine and methacholine on
airways responsiveness were tested on patients with mild
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the day and night. Airway hyperresponsiveness as mea-
sured by the dose required to cause a 20% decline in
FEV1 (PC20FEV1) was greater when the challenges
occurred in the middle of the night (3-5 am) compared
with daytime (Bonnet et al. 1991). A recent review has
confirmed that the circadian variation of bronchial
hyperreactivity to different agents in asthma is more
profound during the night, except to cold dry air, which
shows a peak in the afternoon (Jarjour 1999). Interest-
ingly, this review also found that the amplitude of circa-
dian oscillation of airway hyperreactivity correlated with
the amplitude of pulmonary function oscillation. The
greater the decline of pulmonary function during the
night in asthmatics, the greater the increase of night
time airways hyperreactivity in asthmatic patients
(Jarjour 1999).
The impairment of lung function at night and early
morning also correlated with the expression of several
core clock genes. A recent study by Ehlers and
colleagues studied the expression pattern of multiple
core clock genes in respiratory tract of mild/moderate
and severe asthmatic patients (Ehlers et al. 2017). They
found reduced expression in 6 core clock genes (includ-
ing Bmal1 and Per2) and higher expression of Clock
gene in asthmatics patients (mild-moderate and severe)
when compared to controls. Similarly, another study
found higher gene expression of Arntl2 (a paralog of
Bmal1) and lower of Per2 in severe asthmatics when
compared to mild asthmatics and healthy donors (Fajt
et al. 2015). This suggests a relationship These findings
are supported by a recent longitudinal study that
demonstrated the association of insomnia and risk of
developing asthma in approximately 18,000 participants
(Brumpton et al. 2017).
In the context of treatment, similar to COPD, genes as-
sociated with asthma display circadian oscillation patterns
of expression in rats lungs and some of these genes may
represent asthma drug targets i.e. Selectin P (Selp),
Adenosine A2a receptor (Adora2a), Hepatocyte growth
factor (Hgf ), Myristoylated Ala-rich PKC substrate
(Marcks) and Adrenergic-2 receptor (Adrb2) (Sukumaran
et al. 2011) using chronotherapy. Research on the circa-
dian patterns of disease as well as on potential to use
chronotherapy on both asthma and allergic rhinitis has
been accumulating for decades (Smolensky et al. 2007).
As always, more research needs to be undertaken in order
to apply chronotherapy in asthma but it is one of the most
promising diseases to take advantage of time of day to
significantly improve therapeutic results.
Conclusion
In recent years, mounting evidence has demonstrated that
the immune system displays circadian oscillations (seereviews (Labrecque and Cermakian 2015; Nakao 2014;
Scheiermann et al. 2013; Cermakian et al. 2013; Cerma-
kian et al. 2014)). Pro-inflammatory cytokines are elevated
during rest time and anti-inflammatory cytokines are ele-
vated during activity time. Organisms display stronger im-
mune responses during the rest period and early active
period as compared to other times of the day. Oscillations
in immune function are observed in immune challenges
(such as LPS challenge or bacterial infection) as well as in
disease, including autoimmune and inflammatory diseases.
Although the precise mechanism by which the circadian
clocks regulate immune function are unclear, there is a
clear role for both central and peripheral clocks in regulat-
ing the immune response. For example, the SCN regulates
the recruitment of leukocytes to tissues and regulates
clock gene expression in immune system tissues and cells
as well as oscillations in cytokine production. Further-
more, immune function is also regulated through SCN-
mediation of hormones (cortisol, melatonin). Peripheral
clocks found in many cells and tissues, including those
composing the immune system, also regulate circadian os-
cillations of immune functions. Overall, the interplay be-
tween circadian physiology and disease is complex and is
further complicated by the bi-directional nature of these
systems. Thus, not only does the circadian clock regulate
immune function but inflammation will in turn affect the
circadian clock and the pathways it regulates. Altogether,
the interaction and inter-regulation of the circadian and
immune systems seems to be directed at optimizing im-
mune responses around the clock.
In respiratory diseases, signs and symptoms as well
as severity show circadian variability across the 24-h
cycle. Specifically, obstructive airways diseases and
allergic rhinitis demonstrate increased inflammation
and disease severity at night. Consequently, exposure
to inflammatory insults at night also has greater
effects. Altogether, evidence suggests that inflamma-
tory diseases may be response to chronotherapy to
improve disease control due to circadian clock
control of symptoms and exacerbations. If medicine is
evolving towards a more personalized approach this
will certainly be an aspect to consider. Chronotherapy
into clinical trials studies with existing and new drugs
are needed to test whether outcomes can be
improved in inflammatory diseases when therapy is
administered at different times of day. Assessing
circadian periodicity in humans in field studies are
also required to understand the influence on patho-
physiological processes and therapies. Overall, a better
understanding of the circadian clock regulation of the
immune system will improve the understanding of the
pathophysiology of inflammatory disease and this
could lead to development of more effective chron-
otherapeutic strategies.
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